$CBDL CBD Life Sciences Subsidiary LBC Bioscience
Post# of 1088
(Total Views: 453)
Posted On: 03/25/2020 7:50:24 AM
$CBDL CBD Life Sciences Subsidiary LBC Bioscience Launches First CBD Proprietary Tablet.
CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience "LBC BIO" is pleased to announce in addition to our two stores , we have finalized the formulization of our "NEW PRODUCT" PROPRIETARY PURE CBD TABLET. The product will be packaged in a jar that will consist of 30 tablets. The product helps consumers with pain relief, soreness reduction, muscle tension and more.
You can preorder now on our website www.lbcbioscienceinc.com. Shipments are expected to leave our facilities in approximately 15 business days. CBD has shown encouraging signs for health and wellness and has become increasingly more acceptable to the public and society.
Lisa Nelson, CEO of CBD Life Sciences, Inc. commented "We are excited to launch our new CBD Tablet to the public, our company has worked hard to design this recently developed product. The CBD Sector is a billion-dollar industry that keeps on growing and we are grateful to be a part of it."
About CBD Life Sciences Inc.
CBD Life Sciences Inc. is a publicly traded company having its common shares quoted on the OTC Markets under the symbol ‘CBDL'. The Company's main focus is to identify, evaluate and acquire undervalued opportunities with the objective of increasing shareholder value. The acquisition of LBC Bioscience Inc. is the first in the CBD space and the Company is actively pursuing for additional opportunities within this emerging sector.
CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience "LBC BIO" is pleased to announce in addition to our two stores , we have finalized the formulization of our "NEW PRODUCT" PROPRIETARY PURE CBD TABLET. The product will be packaged in a jar that will consist of 30 tablets. The product helps consumers with pain relief, soreness reduction, muscle tension and more.
You can preorder now on our website www.lbcbioscienceinc.com. Shipments are expected to leave our facilities in approximately 15 business days. CBD has shown encouraging signs for health and wellness and has become increasingly more acceptable to the public and society.
Lisa Nelson, CEO of CBD Life Sciences, Inc. commented "We are excited to launch our new CBD Tablet to the public, our company has worked hard to design this recently developed product. The CBD Sector is a billion-dollar industry that keeps on growing and we are grateful to be a part of it."
About CBD Life Sciences Inc.
CBD Life Sciences Inc. is a publicly traded company having its common shares quoted on the OTC Markets under the symbol ‘CBDL'. The Company's main focus is to identify, evaluate and acquire undervalued opportunities with the objective of increasing shareholder value. The acquisition of LBC Bioscience Inc. is the first in the CBD space and the Company is actively pursuing for additional opportunities within this emerging sector.
(0)
(0)